Annual Meeting

Processing and translating RNA in health and disease

Katrin Karbstein Jeremy Wilusz
By Katrin Karbstein and Jeremy Wilusz
Sept. 20, 2023

The field of RNA biology has yielded some of the most widely popularized scientific findings in the last two decades. Not only are many researchers using siRNAs and CRISPR on a daily basis, but we wonder how we ever could have not known about their existence. Yet, these are only the tip of the iceberg of exciting RNA-dependent regulation in biology that will be addressed in depth in this session.

Tracing the life of an RNA, including how it is transcribed, processed and spliced in the nucleus in association with chromatin is one focus. A second topic will be around translation into protein, with a particular focus on the underlying molecular mechanisms, ribosome specialization and gene-specific effects. Finally, several talks will discuss how these RNA regulatory mechanisms are dysregulated in neurodegenerative diseases and cancer.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.

These studies, presented by leading experts in RNA biology, will provide not just a global overview of an increasingly important field, with enormous potential for future discoveries, but also explain why RNA is considered one of the most promising drug targets and platforms. If you want to be ready for the next CRISPR, you will attend this session.

Keywords: Ribosomes, translation, RNA processing, RNA and disease, splicing, chromatin, CRISPR and immunity.

Who should attend:  Students and postdocs who want to hear about one of the most rapidly expanding fields in biology, educators who want to make sure what they are teaching is current and curious people who want to know what all the hype is about. And, of course, RNA junkies who can’t get enough.

Theme song:  “Friend Like Me” from “Aladdin,” because RNA can do it all.

This session is powered by ATP and other ribonucleotides

RNA biology

RNA biogenesis and processing

Chair: Olga Anczukow

Tracy L. JohnsonUniversity of California, Los Angeles

Hiten D. MadhaniUniversity of California, San Francisco

Jeremy E. WiluszBaylor College of Medicine

Joshua T. MendellUniversity of Texas Southwestern Medical Center

Ribosomes and translation

Chair: Katrin Karbstein

Shu-ou ShanCalifornia Institute of Technology

Ruben L. GonzalezColumbia University

Homa GhaleiEmory University

Amy S.Y. LeeDana–Farber Cancer Institute; Harvard Medical School

RNA and disease

Chair: Jeremy E. Wilusz

Blake WiedenheftMontana State University

Shuying SunJohns Hopkins University

Olga AnczukowJackson Laboratory for Genomic Medicine

Katrin KarbsteinUF Scripps Institute for Biomedical Innovation & Technology

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Katrin Karbstein
Katrin Karbstein

Katrin Karbstein is a professor at UF Scripps in Jupiter, Florida, where she also works on education outreach and diversity, equity and inclusion issues.

Jeremy Wilusz
Jeremy Wilusz

Jeremy Wilusz is an associate professor at Baylor College of Medicine.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder
Journal News

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder

Sept. 16, 2025

Lipid profiling in a rare disease mouse model reveals metabolic shifts and inflammation in the retinal pigment epithelium — offering promising biomarker leads to combat blindness.

How sugars shape Marfan syndrome
Journal News

How sugars shape Marfan syndrome

Sept. 10, 2025

Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.